Skip to main content

Table 4 Cox regression and log rank analysis: Luminal A-like vs. other subtypes

From: Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy

   Hazard Ratio Log-Rank Test
Effect Subset Estimate 95% CIs p-value p-value
Luminal A-like vs. other subtypes all patients 0.350 0.16–0.76 0.0078 0.0053
0–3 positive nodes 0.370 0.16–0.85 0.0184 0.0141
node negative 0.344 0.14–0.86 0.0234 0.0177
Luminal-A-like vs. Luminal B-like all patients 0.37 0.19–0.81 0.0141 0.0106